Jeff Yass’s Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest JHY Stock Holding History

Jeff Yass’s Portfolio JHY Stock Details JHY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-112,167	Closed	-$1.06M	–	12102
2020 Q3	$1.06M	Buy	112,167 +80,274	+252%	+$758K	﹤0.01%	5979
2020 Q2	$297K	Buy	+31,893	New	+$293K	﹤0.01%	8386
2019 Q4	–	Sell	-31,423	Closed	-$312K	–	11086
2019 Q3	$312K	Buy	+31,423	New	+$314K	﹤0.01%	8224
2019 Q2	–	Sell	-13,594	Closed	-$135K	–	11134
2019 Q1	$135K	Buy	+13,594	New	+$136K	﹤0.01%	8124
2018 Q2	–	Sell	-17,903	Closed	-$176K	–	10774
2018 Q1	$176K	Buy	+17,903	New	+$177K	﹤0.01%	8423
2017 Q4	–	Sell	-15,423	Closed	-$156K	–	10190
2017 Q3	$156K	Buy	+15,423	New	+$156K	﹤0.01%	8171

Jeff Yass's JHY Position: Q4 2020 in Review

Jeff Yass sold out of Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest (JHY) in Q4 2020, closing a stake of 112,167 shares — an estimated $1.06M sold.

Jeff Yass first reported a position in JHY in Q3 2017 and held it in 6 quarters. The position peaked at $1.06M in Q3 2020. 0 funds tracked by Wall St. Rank hold JHY as of Q4 2020.

Jeff Yass reported no remaining Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position as of Q4 2020 after selling out during the quarter.
Jeff Yass sold 112,167 Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest shares in Q4 2020, an estimated $1.06M.
Jeff Yass first reported a position in Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest in Q3 2017 and held it in 6 quarters.
Jeff Yass's Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position peaked at $1.06M in Q3 2020.
0 funds tracked by Wall St. Rank held Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.